this post was submitted on 11 Apr 2024
167 points (85.5% liked)
Technology
60093 readers
2633 users here now
This is a most excellent place for technology news and articles.
Our Rules
- Follow the lemmy.world rules.
- Only tech related content.
- Be excellent to each another!
- Mod approved content bots can post up to 10 articles per day.
- Threads asking for personal tech support may be deleted.
- Politics threads may be removed.
- No memes allowed as posts, OK to post as comments.
- Only approved bots from the list below, to ask if your bot can be added please contact us.
- Check for duplicates before posting, duplicates may be removed
Approved Bots
founded 2 years ago
MODERATORS
you are viewing a single comment's thread
view the rest of the comments
view the rest of the comments
Comparing Theranos' claims with the state of the art at the time should've revealed that they were implausible: some blood tests genuinely require a substantial amount of blood in order to properly process and separate and look for a statistically valid measurement of something about that blood, because blood isn't homogenous and the act of drawing blood actually changes it.
Comparing this embryo screening claim with the state of the art is comparatively less of a leap. It's just genetic sequencing, which has already advanced to the point where an entire genome can be sequenced with a tiny number of cells (including some single-cell sequencing techniques that are more complex and less reliable), plus actual correlative analysis of specific genes, plugging into existing research (the way 23 and me can do it for like $20).
I have some skepticism, but this business's model really seems to be assembling steps that others have already established, and not inventing anything new.